➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
McKinsey
AstraZeneca
Johnson and Johnson
McKesson

Last Updated: April 12, 2021

DrugPatentWatch Database Preview

Litigation Details for Bayer Schering Pharma AG v. Mylan Pharmaceuticals Inc. (D. Nev. 2011)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Bayer Schering Pharma AG v. Mylan Pharmaceuticals Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Bayer Schering Pharma AG v. Mylan Pharmaceuticals Inc. (D. Nev. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-08-15 28 USPTO issued United States Patent No. 6,787,531 12 (“the ’531 Patent”), titled “Pharmaceutical composition… PATENT-IN-SUIT 2 59. The patent-in-suit is United States Reissue Patent No. 37,564… the patents-in-suit 4 is United States Reissue Patent No. 37,564 (“the ‘564 reissue patent”). … the patent as the inventors of the ‘564 reissue patent, and that the ‘564 13 reissue patent purports…564 reissue patent. Bayer attaches a true and correct copy of 8 the ’564 reissue patent as Exhibit External link to document
2011-09-09 30 and assignee of United States Patent 4 No. 6,787,531 (“the ’531 patent”), which is dated September … of United States 3 Reissue Patent No. 37,564 (“the ’564 patent”), which is dated February 26, 2002…and assignee of United States Patent 14 No. 5,569,652 (“the ’652 patent”), which is dated October 29…and assignee of United States Patent 21 No. 5,798,338 (“the ’338 patent”), which is dated August 25,…and assignee of United States Patent 12 No. 6,933,395 (“the ’395 patent”), which is dated August 23, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Johnson and Johnson
Boehringer Ingelheim
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.